ACE and heart failure: The European Society of Cardiology, American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America have recommended ARNIs as replacement for the ACE inhibitors in the management of heart failure especially those with reduced ejection fraction remaining symptomatic and belonging to the New York Heart Association (NYHA) classes II to IV [13, 14].